Drug Shortage Report for OMNARIS
Report ID | 175522 |
Drug Identification Number | 02303671 |
Brand name | OMNARIS |
Common or Proper name | Omnaris |
Company Name | COVIS PHARMA GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CICLESONIDE |
Strength(s) | 50MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL NASAL |
Packaging size | 120 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-12-05 |
Actual start date | 2022-12-05 |
Estimated end date | 2022-12-16 |
Actual end date | 2022-12-09 |
Shortage status | Resolved |
Updated date | 2024-02-07 |
Company comments | Shortage was resolved December 9 2022. There is currently no shortage of Omnaris. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | GRAFENAUWEG 12 ZUG, ZUG SWITZERLAND 6300 |
Company contact information | Covis Pharma GmbH Grafenauweg 12 Zug, 6300 Switzerland |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-11-24 | English | Compare |
v2 | 2022-11-24 | English | Compare |
v3 | 2022-11-24 | French | Compare |
v4 | 2022-11-24 | French | Compare |
v5 | 2022-11-24 | French | Compare |
v6 | 2022-11-24 | English | Compare |
v7 | 2022-11-24 | French | Compare |
v8 | 2022-12-06 | English | Compare |
v9 | 2024-02-07 | English | Compare |
v10 | 2024-02-07 | French | Compare |
v11 | 2024-02-07 | French | Compare |
Showing 1 to 11 of 11